IQVIA Holdings (IQV) Financials: History & Chart

IQVIA Holdings Inc. (IQV)IQVIQVIA Holdings Inc.

About IQVIA Holdings Inc.

IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.

Durham, NC

93,000 employees

www.iqvia.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Ari Bousbib

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024	Quarter ended Jun 2024
Revenue	16.63B	4.15B	4.36B	4.10B	4.02B	3.83B	3.96B	3.90B	3.81B
Cost of Goods Sold	12.29B	2.80B	4.07B	2.73B	2.69B	2.53B	2.58B	2.52B	2.76B
Gross Profit	4.34B	1.35B	292.00M	1.37B	1.32B	1.30B	1.38B	1.38B	1.06B
Gross Profit Margin	26.1%	32.6%	6.7%	33.5%	32.9%	33.9%	34.8%	35.4%	27.7%
Total Operating Expenses	2.04B	841.00M	-440.00M	820.00M	817.00M	802.00M	752.00M	828.00M	509.00M
Research & Development	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Selling, General & Administrative	1.99B	502.00M	468.00M	514.00M	509.00M	508.00M	453.00M	522.00M	509.00M
Operating Income (EBIT)	2.31B	514.00M	732.00M	553.00M	506.00M	496.00M	626.00M	550.00M	548.00M
Operating Margin	13.9%	12.4%	16.8%	13.5%	12.6%	13.0%	15.8%	14.1%	14.4%
Income Before Tax (EBT)	1.63B	328.00M	572.00M	408.00M	323.00M	310.00M	549.00M	350.00M	438.00M
Interest Income	40.00M	6.00M	11.00M	13.00M	10.00M	11.00M	11.00M	13.00M	12.00M
Interest Expense	756.00M	192.00M	193.00M	189.00M	182.00M	165.00M	171.00M	170.00M	163.00M
Other Income/Expense	-674.00M	-186.00M	-160.00M	-145.00M	-183.00M	-186.00M	-77.00M	-201.00M	-110.00M
Net Income	1.39B	274.00M	514.00M	331.00M	266.00M	249.00M	437.00M	285.00M	363.00M
Income Tax Expense	250.00M	59.00M	58.00M	76.00M	57.00M	61.00M	112.00M	65.00M	75.00M
Net Profit Margin	8.3%	6.6%	11.8%	8.1%	6.6%	6.5%	11.0%	7.3%	9.5%
EBITDA	3.47B	802.00M	1.05B	839.00M	782.00M	761.00M	929.00M	828.00M	817.00M
EBITDA Margin	20.9%	19.3%	24.0%	20.5%	19.5%	19.9%	23.5%	21.3%	21.4%
Depreciation & Amortization	1.17B	288.00M	317.00M	286.00M	276.00M	265.00M	303.00M	278.00M	269.00M
EPS Basic	8.14	1.63	3.02	1.94	1.55	1.42	2.44	1.57	1.99
EPS Diluted	8.07	1.61	2.99	1.93	1.54	1.40	2.42	1.55	1.97
Shares Outstanding	168.40M	168.40M	170.00M	170.20M	171.80M	175.70M	178.90M	182.10M	182.20M
Diluted Shares Outstanding	169.80M	169.80M	171.90M	171.70M	173.20M	177.40M	180.80M	184.20M	184.30M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	16.31B	15.40B	14.98B	14.41B	13.87B	11.36B	11.09B	10.41B
Cost of Goods Sold	12.02B	10.03B	9.74B	9.38B	9.23B	7.50B	7.30B	6.75B
Gross Profit	4.29B	5.38B	5.24B	5.03B	4.64B	3.86B	3.79B	3.67B
Gross Profit Margin	26.3%	34.9%	35.0%	34.9%	33.5%	34.0%	34.2%	35.2%
Total Operating Expenses	2.00B	3.17B	3.26B	3.23B	3.25B	3.13B	3.01B	2.92B
Research & Development	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Selling, General & Administrative	2.00B	1.99B	2.05B	2.07B	1.96B	1.79B	1.73B	1.72B
Operating Income (EBIT)	2.29B	2.20B	1.98B	1.80B	1.39B	731.00M	777.00M	741.00M
Operating Margin	14.0%	14.3%	13.2%	12.5%	10.0%	6.4%	7.0%	7.1%
Income Before Tax (EBT)	1.61B	1.67B	1.46B	1.35B	1.13B	380.00M	343.00M	343.00M
Interest Income	45.00M	47.00M	36.00M	13.00M	6.00M	6.00M	9.00M	8.00M
Interest Expense	729.00M	670.00M	672.00M	416.00M	375.00M	416.00M	447.00M	414.00M
Other Income/Expense	-674.00M	-533.00M	-518.00M	-448.00M	-259.00M	-351.00M	-434.00M	-398.00M
Net Income	1.36B	1.37B	1.36B	1.09B	966.00M	279.00M	191.00M	259.00M
Income Tax Expense	252.00M	296.00M	101.00M	260.00M	163.00M	72.00M	116.00M	59.00M
Net Profit Margin	8.3%	8.9%	9.1%	7.6%	7.0%	2.5%	1.7%	2.5%
EBITDA	3.43B	3.32B	3.10B	2.93B	2.66B	2.02B	1.98B	1.88B
EBITDA Margin	21.0%	21.5%	20.7%	20.3%	19.2%	17.8%	17.8%	18.1%
Depreciation & Amortization	1.14B	1.11B	1.13B	1.13B	1.26B	1.29B	1.20B	1.14B
EPS Basic	7.91	7.57	7.39	5.82	5.05	1.46	0.98	1.27
EPS Diluted	7.84	7.49	7.29	5.72	4.95	1.43	0.96	1.24
Shares Outstanding	171.90M	181.30M	183.80M	187.60M	191.40M	191.30M	195.10M	203.70M
Diluted Shares Outstanding	173.50M	183.40M	186.30M	190.60M	195.00M	195.00M	199.60M	208.20M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.